Plasmonix

About:

Plasmonix commercializes Metal Enhanced Fluorescence technology to transform the use of fluorescence and luminescence.

Website: http://plasmonixinc.com

Top Investors: Maryland Venture Fund

Description:

Plasmonix is a biotechnology company that commercializes Metal Enhanced Fluorescence (MEF) technology to transform the use of fluorescence and luminescence which enhances the emitted light signal, facilitating detection to as low as several hundred molecules, which was heretofore not possible. The company also develops cell lysis device that uses microwave energy to break open the contents of bacteria and cells to enable detection of their molecular contents and genetic fingerprint. Plasmonix was incorporated in 2009 and is based in Baltimore, Maryland

Total Funding Amount:

$2.91M

Estimated Revenue Range:

Less than $1M

Headquarters Location:

Baltimore, Maryland, United States

Founded Date:

2009-01-01

Contact Email:

info(AT)plasmonixinc.com

Founders:

William Gust

Number of Employees:

1-10

Last Funding Date:

2014-06-13

IPO Status:

Private

Industries:

© 2025 bioDAO.ai